Industry: Service & Software
Published Date: 2026-03-12
Pages: 114 Pages
Report ld: 6217617
Request Sample
Customized Report
Pharmaceutical Decommissioning Service Market Size(US$)

CAGR 2026-2032
5.6%
Market Size,2032
USD 1,170
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Decommissioning Service market was valued at US$ 803 million in 2025 and is anticipated to reach US$ 1170 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Pharmaceutical Decommissioning Service is a one-stop professional service from assessment, planning, demolition, disposal to site restoration and reuse for production facilities, equipment, plants and related systems that are decommissioned by pharmaceutical companies due to equipment aging, technology upgrades, regulatory requirements or corporate strategy adjustments. It covers equipment compliance inspection, hazardous substance treatment, waste environmental recycling, safe demolition of building structures and site ecological restoration, ensuring that the decommissioning process complies with the Good Manufacturing Practice (GMP) for pharmaceuticals, environmental protection regulations and safety production standards. At the same time, through resource recycling and site function reconstruction, it helps companies achieve sustainable development goals.
The North American market for Pharmaceutical Decommissioning Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Pharmaceutical Decommissioning Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Pharmaceutical Decommissioning Service in Pharmaceutical Manufacturers is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Pharmaceutical Decommissioning Service include KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, Qualitech Environmental Services, Hughes & Salvidge, Divestiture, Pharmagraph, RVA Group, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Pharmaceutical Decommissioning Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Decommissioning Service. The Pharmaceutical Decommissioning Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Decommissioning Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Decommissioning Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pharmaceutical Decommissioning Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Decommissioning Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Equipment Decommissioning Service
1.2.3 Facility Decommissioning Service
1.2.4 Laboratory Decommissioning Service
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Decommissioning Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Manufacturers
1.3.3 Pharmaceutical CDMO
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Decommissioning Service Market Perspective (2021–2032)
2.2 Global Pharmaceutical Decommissioning Service Growth Trends by Region
2.2.1 Global Pharmaceutical Decommissioning Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharmaceutical Decommissioning Service Historic Market Size by Region (2021–2026)
2.2.3 Pharmaceutical Decommissioning Service Forecasted Market Size by Region (2027–2032)
2.3 Pharmaceutical Decommissioning Service Market Dynamics
2.3.1 Pharmaceutical Decommissioning Service Industry Trends
2.3.2 Pharmaceutical Decommissioning Service Market Drivers
2.3.3 Pharmaceutical Decommissioning Service Market Challenges
2.3.4 Pharmaceutical Decommissioning Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Decommissioning Service Players by Revenue
3.1.1 Global Top Pharmaceutical Decommissioning Service Players by Revenue (2021–2026)
3.1.2 Global Pharmaceutical Decommissioning Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharmaceutical Decommissioning Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Decommissioning Service Revenue
3.4 Global Pharmaceutical Decommissioning Service Market Concentration Ratio
3.4.1 Global Pharmaceutical Decommissioning Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Decommissioning Service Revenue in 2025
3.5 Global Key Players of Pharmaceutical Decommissioning Service Head Offices and Areas Served
3.6 Global Key Players of Pharmaceutical Decommissioning Service, Products and Applications
3.7 Global Key Players of Pharmaceutical Decommissioning Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pharmaceutical Decommissioning Service Breakdown Data by Type
4.1 Global Pharmaceutical Decommissioning Service Historic Market Size by Type (2021–2026)
4.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Type (2027–2032)
5 Pharmaceutical Decommissioning Service Breakdown Data by Application
5.1 Global Pharmaceutical Decommissioning Service Historic Market Size by Application (2021–2026)
5.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pharmaceutical Decommissioning Service Market Size (2021–2032)
6.2 North America Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharmaceutical Decommissioning Service Market Size by Country (2021–2026)
6.4 North America Pharmaceutical Decommissioning Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Decommissioning Service Market Size (2021–2032)
7.2 Europe Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharmaceutical Decommissioning Service Market Size by Country (2021–2026)
7.4 Europe Pharmaceutical Decommissioning Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Decommissioning Service Market Size (2021–2032)
8.2 Asia-Pacific Pharmaceutical Decommissioning Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharmaceutical Decommissioning Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharmaceutical Decommissioning Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharmaceutical Decommissioning Service Market Size (2021–2032)
9.2 Latin America Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharmaceutical Decommissioning Service Market Size by Country (2021–2026)
9.4 Latin America Pharmaceutical Decommissioning Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Decommissioning Service Market Size (2021–2032)
10.2 Middle East & Africa Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KDC Veolia
11.1.1 KDC Veolia Company Details
11.1.2 KDC Veolia Business Overview
11.1.3 KDC Veolia Pharmaceutical Decommissioning Service Introduction
11.1.4 KDC Veolia Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.1.5 KDC Veolia Recent Development
11.2 RCS Pharma
11.2.1 RCS Pharma Company Details
11.2.2 RCS Pharma Business Overview
11.2.3 RCS Pharma Pharmaceutical Decommissioning Service Introduction
11.2.4 RCS Pharma Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.2.5 RCS Pharma Recent Development
11.3 Technical Safety Services
11.3.1 Technical Safety Services Company Details
11.3.2 Technical Safety Services Business Overview
11.3.3 Technical Safety Services Pharmaceutical Decommissioning Service Introduction
11.3.4 Technical Safety Services Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.3.5 Technical Safety Services Recent Development
11.4 ISPE
11.4.1 ISPE Company Details
11.4.2 ISPE Business Overview
11.4.3 ISPE Pharmaceutical Decommissioning Service Introduction
11.4.4 ISPE Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.4.5 ISPE Recent Development
11.5 Brilliant Equipment Services
11.5.1 Brilliant Equipment Services Company Details
11.5.2 Brilliant Equipment Services Business Overview
11.5.3 Brilliant Equipment Services Pharmaceutical Decommissioning Service Introduction
11.5.4 Brilliant Equipment Services Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.5.5 Brilliant Equipment Services Recent Development
11.6 Qualitech Environmental Services
11.6.1 Qualitech Environmental Services Company Details
11.6.2 Qualitech Environmental Services Business Overview
11.6.3 Qualitech Environmental Services Pharmaceutical Decommissioning Service Introduction
11.6.4 Qualitech Environmental Services Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.6.5 Qualitech Environmental Services Recent Development
11.7 Hughes & Salvidge
11.7.1 Hughes & Salvidge Company Details
11.7.2 Hughes & Salvidge Business Overview
11.7.3 Hughes & Salvidge Pharmaceutical Decommissioning Service Introduction
11.7.4 Hughes & Salvidge Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.7.5 Hughes & Salvidge Recent Development
11.8 Divestiture
11.8.1 Divestiture Company Details
11.8.2 Divestiture Business Overview
11.8.3 Divestiture Pharmaceutical Decommissioning Service Introduction
11.8.4 Divestiture Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.8.5 Divestiture Recent Development
11.9 Pharmagraph
11.9.1 Pharmagraph Company Details
11.9.2 Pharmagraph Business Overview
11.9.3 Pharmagraph Pharmaceutical Decommissioning Service Introduction
11.9.4 Pharmagraph Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.9.5 Pharmagraph Recent Development
11.10 RVA Group
11.10.1 RVA Group Company Details
11.10.2 RVA Group Business Overview
11.10.3 RVA Group Pharmaceutical Decommissioning Service Introduction
11.10.4 RVA Group Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.10.5 RVA Group Recent Development
11.11 DSM Demolition
11.11.1 DSM Demolition Company Details
11.11.2 DSM Demolition Business Overview
11.11.3 DSM Demolition Pharmaceutical Decommissioning Service Introduction
11.11.4 DSM Demolition Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.11.5 DSM Demolition Recent Development
11.12 KERAMIDA Inc
11.12.1 KERAMIDA Inc Company Details
11.12.2 KERAMIDA Inc Business Overview
11.12.3 KERAMIDA Inc Pharmaceutical Decommissioning Service Introduction
11.12.4 KERAMIDA Inc Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.12.5 KERAMIDA Inc Recent Development
11.13 Downwell Enabling Solutions
11.13.1 Downwell Enabling Solutions Company Details
11.13.2 Downwell Enabling Solutions Business Overview
11.13.3 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Introduction
11.13.4 Downwell Enabling Solutions Revenue in Pharmaceutical Decommissioning Service Business (2021–2026)
11.13.5 Downwell Enabling Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1170 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 143
USD 4900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market size was US$ 803 million in 2025 and is forecast to reach a readjusted size of US$ 1170 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 93
USD 4250.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 803 million in 2025 and is projected to reach US$ 1170 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 106
USD 3950.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-06-18
Pages: 119
USD 3950.00
(Single User License)
The global Pharmaceutical Decommissioning Service market size was US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-06-18
Pages: 93
USD 4250.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was valued at US$ 785 million in the year 2024 and is projected to reach a revised size of US$ 1114 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published Date: 2025-06-18
Pages: 84
USD 2900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1114 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published Date: 2025-06-18
Pages: 145
USD 4900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1170 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 143
The global Pharmaceutical Decommissioning Service market size was US$ 803 million in 2025 and is forecast to reach a readjusted size of US$ 1170 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 93
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 803 million in 2025 and is projected to reach US$ 1170 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 106
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-06-18
Pages: 119
The global Pharmaceutical Decommissioning Service market size was US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-06-18
Pages: 93
The global market for Pharmaceutical Decommissioning Service was valued at US$ 785 million in the year 2024 and is projected to reach a revised size of US$ 1114 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-06-18
Pages: 84
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1114 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published: 2025-06-18
Pages: 145
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now